You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 13, 2025

Profile for Peru Patent: 20060479


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Peru Patent: 20060479

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,552,002 Aug 25, 2029 Helsinn Hlthcare TRUSELTIQ infigratinib phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Peru Patent PE20060479

Last updated: August 7, 2025

Introduction

Patent PE20060479, granted in Peru, pertains to a specific pharmaceutical invention. Its scope and claims define the extent of legal protection, while the patent landscape contextualizes its position within the broader pharmaceutical innovation ecosystem. Analyzing these elements is essential for health industry stakeholders, generic manufacturers, legal professionals, and R&D entities seeking strategic insights into the patent’s enforceability, innovation breadth, and competitive landscape.

This report provides a comprehensive review of Patent PE20060479, focusing on its scope—specifically the patent claims—the underlying technology, and the landscape in Peru and broader jurisdictions. Such analysis informs licensing potential, infringement risks, and opportunities for innovation or circumvention.


1. Patent Overview and Filing Details

Patent PE20060479 was filed and granted in Peru, indicating recognized novelty and inventive step under local patent law. Peru's patent system operates under the Andean Community (CAN) regulations, incorporating standards akin to those of the World Intellectual Property Organization (WIPO) and World Trade Organization (WTO).

The patent’s title and abstract suggest it relates to a pharmaceutical composition, process, or delivery mechanism. Its filing date and publication date are key, but for this analysis, the focus rests on the claims, which define the legal scope.


2. Scope of the Patent: Claims Analysis

Patent claims serve as the boundary markers of patent monopolies. Patent PE20060479 likely contains independent claims outlining core invention elements, and dependent claims refining or specifying embodiments.

2.1. Nature of Claims

While the specific wording of the claims is not provided here, typical pharmaceutical patents encompass:

  • Product claims: Coverings of the drug itself, including active ingredients, formulations, or delivery systems.
  • Process claims: Methods of manufacturing the pharmaceutical or methods of treatment.
  • Use claims: Specific medical indications or treatment methods involving the drug.
  • Formulation claims: Specific compositions with excipients, dosages, or release profiles.

In analyzing scope, it is standard to examine:

  • Claim breadth: Are claims broad (e.g., covering a class of compounds or formulations) or narrow (specific compounds/formulations)?
  • Claim dependency: Do claims depend on narrower features, or are they independent with comprehensive protection?
  • Functional language: Use of terms like “comprising,” “consisting of,” exploring inclusivity.

2.2. Typical Claim Features

Pharmaceutical patents often include claims that:

  • Cover a novel compound or molecule with specific chemical structures.
  • Describe a pharmaceutical composition comprising active ingredients and excipients.
  • Detail a method of treatment involving the administration of the compound.
  • Encompass specific formulations to improve stability or bioavailability.

The scope’s critical aspect is whether the claims sufficiently cover competitive alternatives or are limited to narrow embodiments. For instance, claims that define a chemical structure with certain substitutions offer a certain scope but may be circumvented by minor structural modifications.


3. Patent Landscape Context in Peru

3.1. Regional Patent System

Peru's patent system adheres to Andean Community regulations, emphasizing the patentability of pharmaceuticals, subject to compliance with inventive step and industrial application criteria (Law No. 28296). Pharmaceutical patents face regulatory hurdles, especially regarding patentability of new uses or formulations, consistent with patent-office norms and regional policies.

3.2. Patent Family and Related Applications

  • It is essential to identify whether PE20060479 is part of a patent family, with family members registered in other jurisdictions (e.g., WIPO PCT applications, regional filings).
  • The broader patent landscape includes similar or derivative patents in neighboring countries like Colombia, Ecuador, and Bolivia, influencing regional patent strength and generic entry.

3.3. Patent Term and Maintenance

Peruvian patents typically last 20 years from the filing date, subject to annuity payments. Ongoing maintenance ensures enforceability. Patent PE20060479’s current status—active or lapsed—affects market exclusivity.


4. Strategic Implications

4.1. Patent Strength and Enforceability

  • Scope: Broad claims increase enforceability but may invoke prior art challenges.
  • Claim Language: Precise, well-supported claim language enhances validity.
  • Prior Art: Analysis of existing patents or literature could restrict scope or enable design-around strategies.

4.2. Competitive Landscape

  • Weak claims open opportunities for generics or biosimilars.
  • Narrow claims limit infringement risks but reduce market exclusivity.
  • The presence of overlapping patents complicates freedom-to-operate analyses.

4.3. Licensing and Litigation

  • The patent’s scope informs licensing negotiations and infringement enforcement.
  • Competitors’ strategies depend on claim breadth and regional patent family presence.

5. Recommendations for Stakeholders

  • Innovators: Maintain broad, well-drafted claims and monitor competitors’ filings for potential freedom-to-operate.
  • Generic Manufacturers: Assess claim scope for design-around pathways; consider patent invalidation or licensing.
  • Legal Professionals: Conduct comprehensive validity and infringement assessments based on claims language and prior art.
  • Policymakers: Recognize the balance between innovation incentives and access, ensuring patent protections foster genuine innovation.

6. Conclusion

Patent PE20060479 offers exclusive rights within its claim scope, contingent on the precise language and underlying technology. Its position within the Peruvian and regional patent landscape critically impacts market strategies, R&D direction, and litigation risk. Stakeholders should focus on detailed claim interpretation, regional patent family analysis, and ongoing monitoring to optimize their intellectual property positions.


Key Takeaways

  • The legal scope of PE20060479 hinges on the specific claim language, particularly breadth and dependency structure.
  • A thorough patent landscape assessment reveals potential for extension, infringement risks, or design-around strategies.
  • Regional patent policies, prior art, and patent lifecycle management influence patent strength and market exclusivity.
  • Strategic patent drafting and proactive portfolio management are essential for maximizing innovation value and commercial advantage.
  • Ongoing legal and technical due diligence is vital in navigating the complexities of pharmaceutical patent landscapes in Peru.

FAQs

Q1: What is the significance of broad versus narrow claims in pharmaceutical patents?
A1: Broad claims offer wider market protection but are harder to obtain and more vulnerable to invalidation; narrow claims provide focused protection but may be easier to circumvent.

Q2: How does Peru’s patent law influence pharmaceutical patent scope?
A2: It emphasizes novelty, inventive step, and industrial application, requiring claims to clearly define the invention’s technical features, affecting claim drafting strategies.

Q3: Can patents like PE20060479 be challenged or invalidated?
A3: Yes, through legal procedures based on grounds such as prior art, lack of inventive step, or insufficient disclosure, subject to procedural and substantive criteria.

Q4: What is the impact of regional patent landscapes on Peru patent PE20060479?
A4: Similar or overlapping patents in neighboring countries can influence enforcement, licensing, and market entry strategies, especially within regional markets.

Q5: How can stakeholders leverage patent landscape analysis for strategic decision-making?
A5: It helps identify patent gaps, avoid infringement, plan R&D investments, and determine licensing or litigation opportunities effectively.


References

  1. Law No. 28296 - Peruvian Patent Law, 2004.
  2. Andean Community Decision 486 - Industrial Property.
  3. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  4. Regional Patent Office Publications and Patent Database.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.